• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human T-cell immunoreceptor with Ig and ITIM domains (TIGIT), Truncated

The recombinant Human TIGIT protein is encoded by the gene of TIGIT (22-141aa). The gene of TIGIT was cloned in a system (E.coli) that supported the expression of TIGIT and translation of messenger RNA. Modification of TIGIT by recombinant DNA technology could lead to the expression of the target protein. The protein was fused with N-terminal 6xHis-SUMO tag in the production. The purity is 90% determined by SDS-PAGE.TIGIT?(VSIG9, VSTM3)?is a protein coding gene that encodes T-cell immunoreceptor with Ig and ITIM domains. According to some studies, TIGIT may have the following features.TIGIT, an inhibitory receptor expressed on lymphocytes, has recently been proposed as a major emerging target for cancer immunotherapy. TIGIT has an intrinsic suppressive function of T cells. The surface protein TIGIT inhibits T cell activation by promoting the generation of mature immunoregulatory dendritic cells. TIGIT is a key inhibitor of the cancer immune cycle. The immunosensor TIGIT regulates antitumor and antiviral CD8+ T cell effector functions. The TIGIT/CD226 axis regulates human T cell function. Interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. TIGIT, a new immunotherapy target, is moving from the lab to the bedside.

ACP02456

The recombinant Human TIGIT protein is encoded by the gene of TIGIT (22-141aa). The gene of TIGIT was cloned in a system (E.coli) that supported the expression of TIGIT and translation of messenger RNA. Modification of TIGIT by recombinant DNA technology could lead to the expression of the target protein. The protein was fused with N-terminal 6xHis-SUMO tag in the production. The purity is 90% determined by SDS-PAGE.TIGIT?(VSIG9, VSTM3)?is a protein coding gene that encodes T-cell immunoreceptor with Ig and ITIM domains. According to some studies, TIGIT may have the following features.TIGIT, an inhibitory receptor expressed on lymphocytes, has recently been proposed as a major emerging target for cancer immunotherapy. TIGIT has an intrinsic suppressive function of T cells. The surface protein TIGIT inhibits T cell activation by promoting the generation of mature immunoregulatory dendritic cells. TIGIT is a key inhibitor of the cancer immune cycle. The immunosensor TIGIT regulates antitumor and antiviral CD8+ T cell effector functions. The TIGIT/CD226 axis regulates human T cell function. Interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. TIGIT, a new immunotherapy target, is moving from the lab to the bedside.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02456 Target NameTIGIT
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range22-141aaMol Weight26.0 kDa
Protein LengthExtracellular DomainPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ495A1
Background Information
  • Uniprot Id

    Q495A1

  • Target Species

    Human

  • Target Name

    TIGIT

  • Target Full Name

    T-cell immunoreceptor with Ig and ITIM domains

  • Target Function

    Binds with high affinity to the poliovirus receptor (PVR) which causes increased secretion of IL10 and decreased secretion of IL12B and suppresses T-cell activation by promoting the generation of mature immunoregulatory dendritic cells.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein.

  • Target Tissue Specificity

    Expressed at low levels on peripheral memory and regulatory CD4+ T-cells and NK cells and is up-regulated following activation of these cells (at protein level).

  • Target Research Area

    Immunology

  • Target Synonyms

    DKFZp667A205; ENSMUSG00000071552; FLJ39873; RGD1563191; T cell immunoreceptor with Ig and ITIM domains; TIGIT; TIGIT_HUMAN; V-set and immunoglobulin domain containing 9; V-set and immunoglobulin domain-containing protein 9; V-set and transmembrane domain containing 3; V-set and transmembrane domain-containing protein 3; VSIG9; VSTM3; Washington University cell adhesion molecule; WUCAM

  • Target Background

    This gene encodes a member of the PVR (poliovirus receptor) family of immunoglobin proteins. The product of this gene is expressed on several classes of T cells including follicular B helper T cells (TFH). The protein has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses.

Inquire Recombinant Human T-cell immunoreceptor with Ig and ITIM domains (TIGIT), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification